Atrás
Precio Mabpharm Limited (02181.HK)
Gráfico del Precio de Acciones 02181.HK
MABPHARM-B (02181.HK)
Mabpharm Limited
HK$0.51
2%
$0.01
Mercado cerrado: Jan 16, 16:00:00 HKT
Estadísticas clave
Cierre Anterior
$0.52
Precio de apertura
$0.5
Rango del día
$0.5 - $0.51
Rango de 52 semanas
$0.25 - $0.94
Volumen
12.0K
Volumen promedio
88.2K
EPS (TTM)
-0.01
Rendimiento de dividendos
--
Cap. de mercado
$2.1B
¿Qué es MABPHARM-B?
Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company is headquartered in Taizhou, Jiangsu and currently employs 383 full-time employees. The company went IPO on 2019-05-31. The Company’s main products include CMAB009 Enlituo (cetuximab β injection), CMAB007 Aomaishu (Omalizumab α for Injection), CMAB008 Leiting (infliximab for injection) and other products. The Company’s products are mainly used for colorectal cancer, asthma, urticaria, rheumatoid arthritis, ulcerative colitis in adults and other diseases. The firm is also engaged in the transfer of intellectual property. The firm mainly conducts its business in the domestic market.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
